RxDoctor Payments Data

Garry Porter, MD

Psychiatry · Wichita, KSNPI 1114921699

Payments from drug & device makers

$774in general payments, 2019–2025

Across 41 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$123
  • Johnson & Johnson$118
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$70
  • Otsuka America Pharmaceutical, Inc.$54
  • Jazz Pharmaceuticals Inc.$54
  • Indivior Inc.$49
  • plus $307 from 10 others

What the payments were for

  • Food & beverage$774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$774 in reported general payments places this provider in the 65th percentile of 259 psychiatry providers in Kansas.

See all psychiatry providers in Kansas

Medicare billing

Part B allowed, 2024
$10,178
Medicare patients
42
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate83$292,890
Abilify MaintenaAripiprazole38$94,917
RexultiBrexpiprazole20$29,679
VraylarCariprazine Hcl18$23,700
Risperdal ConstaRisperidone Microspheres18$22,873
TrintellixVortioxetine Hydrobromide38$22,320
Clozapine160$15,394
Seroquel XrQuetiapine Fumarate24$14,670
Aripiprazole184$11,742
Lurasidone Hcl81$11,478
Asenapine Maleate45$8,990
Divalproex Sodium ErDivalproex Sodium80$6,556
Paliperidone ErPaliperidone34$5,177
Atomoxetine Hcl48$5,042
Divalproex Sodium38$4,785

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$118$315,762101 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$54$124,59658 claims
AbbVieVraylar$35$23,70018 claims
Almatica Pharma LLCSertraline Hcl$34$1,419147 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 259 psychiatry providers in Kansas.

Other psychiatry in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →